All lobbying filings

ACTUM I, LLC

ACTUM I, LLC filed a Q3 report for PRIO PHARMA, INC. on October 19, 2025, reporting $10,000 in lobbying income.

Lobbying for PRIO PHARMA, INC. · pharmaceutical company

All filings by ACTUM I, LLC · Everything PRIO PHARMA, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 19, 2025

Income

$10,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Lobbyists on this filing 3

LAUREN LIPIN

Previously held: Mil Leg Asst/Leg Corresp. Cong. C.A. Dutch Ruppersberger
KEVIN KELLY

Previously held: Chief Counsel/Floor Asst, Sec of the Democratic Conference; Chief Clerk/Maj Staff Dir, Senate VA/HUD Approps Subcomm
JEFFREY REGAN

Previously held: Leg Asst/Policy Advisor, Leg Aide, Leg Corresp., Staff Assistant - Sen. Christopher Dodd

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Budget/Appropriations

FY26 Defense Appropriations bill - Defense Health Program funding; H.R.5371 - Continuing Appropriations and Extensions Act, 2026, S.2882 - Continuing Appropriations and Extensions and Other Matters Act, 2026

Defense

FY26 Defense Appropriations bill - Defense Health Program funding; FY26 National Defense Authorization Act

Bills named in this filing 2

H.R. 5371
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …
S. 2882
Continuing Appropriations and Extensions and Other Matters Act, 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.